Current trends and new methods of detection of SARS-CoV-2 infection

Bibliographic Details
Title: Current trends and new methods of detection of SARS-CoV-2 infection
Authors: Mohammad Mohammadi, Amir Omidi, Hoda Sabati
Source: Cellular, Molecular and Biomedical Reports, Vol 2, Iss 3, Pp 138-150 (2022)
Publisher Information: Global Sciences, 2022.
Publication Year: 2022
Collection: LCC:Medicine
Subject Terms: reverse transcriptase pcr, nanotechnology, crispr, biosensors, artificial intelligence, positron emission tomography, Medicine
More Details: SARS-CoV- 2 is the causative agent of the global pandemic, also known as Covid-19. This virus belongs to a group of coronaviruses and has affected more than ten million people across the globe, causing nearly half a million deaths worldwide. The pandemic has spread worldwide, originating in the Wuhan Hubei province of China in 2019. The disease is a significant challenge as there is no antiviral treatment. This review will address current trends and emerging new methods for detecting SARS-CoV-2 in the laboratoryat present. Reverse transcriptase PCR or RT-PCR is the gold standard for detecting SARS-CoV-2 disease. The seroprevalence of Covid-19 is performed using antibody detection tests using ELISA and antigen detection as rapid tests. In clinical practice, preliminary disease identification is made based on Chest radiographs, computed tomography, and positron emission tomography (PET) scans. As the pandemic has progressed, newer methods of detection like CRISPR, nanotechnology-enabled solutions, and biosensors have emerged as new methods of detecting SARS-CoV-2.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2823-2550
Relation: https://www.cmbr-journal.com/article_154158_8e33a2f1770fd2e5e821616295329f94.pdf; https://doaj.org/toc/2823-2550
DOI: 10.55705/cmbr.2022.345025.1047
Access URL: https://doaj.org/article/c3ea05807ae843ecbe506492ffa0187f
Accession Number: edsdoj.3ea05807ae843ecbe506492ffa0187f
Database: Directory of Open Access Journals
More Details
ISSN:28232550
DOI:10.55705/cmbr.2022.345025.1047
Published in:Cellular, Molecular and Biomedical Reports
Language:English